Citius Oncology (CTOR) Deferred Taxes (2023 - 2026)

Citius Oncology (CTOR) has 4 years of Deferred Taxes data on file, last reported at -$231210.0 in Q1 2026.

• On a quarterly basis, Deferred Taxes fell 187.5% year-over-year to -$231210.0 in Q1 2026; TTM through Mar 2026 was $561510.0, a 55.02% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, up 83.5% from the prior year.
• Deferred Taxes for Q1 2026 stood at -$231210.0, down from $264240.0 in the prior quarter.
• Over the last five years, Deferred Taxes for CTOR reached as high as $432000.0 in Q2 2024 and fell as low as -$231210.0 in Q1 2026.
• Historically, Deferred Taxes has averaged $217110.0 across 4 years, with a median of $264240.0 in 2024.
• Across the five-year window, Deferred Taxes surged 83.5% in 2024 and tumbled 187.5% in 2026, its largest moves.
• Year by year, Deferred Taxes stood at $144000.0 in 2023, then jumped by 83.5% to $264240.0 in 2024, then changed by 0.0% to $264240.0 in 2025, then tumbled by 187.5% to -$231210.0 in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$231210.0 in Q1 2026, $264240.0 in Q4 2025, and $264240.0 in Q3 2025.